Table 1.
Relationship between circ9119 expression and clinical-pathologic features of HCC Patients (N = 20).
| Features | Relative circ9119 expression levels | ||
|---|---|---|---|
| circ9119 low (N = 8) | circ9119 high (N = 12) | p value | |
| Age | |||
| ≤50 | 4 | 5 | 0.682 |
| >50 | 4 | 7 | |
| Gender | |||
| Male | 6 | 9 | 0.560 |
| Female | 2 | 3 | |
| AFP (μg/L) | |||
| ≤20 | 3 | 7 | 0.490 |
| >20 | 5 | 5 | |
| HBV | |||
| Positive | 6 | 7 | 0.508 |
| Negative | 2 | 5 | |
| Liver cirrhosis | |||
| Yes | 7 | 11 | 0.756 |
| No | 1 | 1 | |
| Tumor diameter (cm) | |||
| ≤5 | 6 | 1 | 0.023 |
| >5 | 2 | 11 | |
HCC patients were divided into circ9119 “High” group (relative fold change was higher than the median) and “Low” group (relative fold change was lower than the median).
Differences among variables were assessed by χ2 or Fisher’s exact χ2 test.
HBV Positive hepatitis B virus surface antigen positive, AFP alpha-fetoprotein.